Related references
Note: Only part of the references are listed.The efficacy of combined l-carnitine and l-acetyl carnitine in men with idiopathic oligoasthenoteratozoospermia: A systematic review and meta-analysis
Xuebao Zhang et al.
ANDROLOGIA (2020)
Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
Cecilia Maldonado et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Prevalence of mental disorders in China: a cross-sectional epidemiological study
Yueqin Huang et al.
LANCET PSYCHIATRY (2019)
Acetyl-L-carnitine deficiency in patients with major depressive disorder
Carla Nasca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Depression Is the Leading Cause of Disability Around the World
M.J. Friedrich
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
L-carnitine Supplementation Improves Self-rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis
Kyoko Tashiro et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2017)
L-Carnitine and Acetyl-l-carnitine Roles and Neuroprotection in Developing Brain
Gustavo C. Ferreira et al.
NEUROCHEMICAL RESEARCH (2017)
Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit
S. I. Gavrilova et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2016)
Molecular biomarkers of depression
Anand Gururajan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance
Benedetta Bigio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
RAPID-ACTING ANTIDEPRESSANT-LIKE EFFECTS OF ACETYL-L-CARNITINE MEDIATED BY PI3K/AKT/BDNF/VGF SIGNALING PATHWAY IN MICE
W. Wang et al.
NEUROSCIENCE (2015)
EFFICACY AND ACCEPTABILITY OF ACUTE TREATMENTS FOR PERSISTENT DEPRESSIVE DISORDER: A NETWORK META-ANALYSIS
Levente Kriston et al.
DEPRESSION AND ANXIETY (2014)
Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients
Hui-min Fan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
A review of current evidence for acetyl-L-carnitine in the treatment of depression
Sheng-Min Wang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
A review of the role of social cognition in major depressive disorder
Michael James Weightman et al.
FRONTIERS IN PSYCHIATRY (2014)
Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond
Marco Onofrj et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
Shigeyuki Chaki et al.
NEUROPHARMACOLOGY (2013)
Upregulation of mGlu2 Receptors via NF-κB p65 Acetylation Is Involved in the Proneurogenic and Antidepressant Effects of Acetyl-L-Carnitine
Bruna Cuccurazzu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors
Carla Nasca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study
Cheng-Ta Li et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients
Takeki Adachi et al.
NEPHROLOGY (2012)
Chronic acetyl-L-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice
Olav B. Smeland et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression
Renaud Massart et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects
Michael Messaoudi et al.
BRITISH JOURNAL OF NUTRITION (2011)
Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers
Aurelie Blugeot et al.
JOURNAL OF NEUROSCIENCE (2011)
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Heath D. Schmidt et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects
Giovanni Martinotti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Acylcarnitines: Role in brain
Lauren L. Jones et al.
PROGRESS IN LIPID RESEARCH (2010)
ACETYL-L-CARNITINE PROVIDES EFFECTIVE IN VIVO NEUROPROTECTION OVER 3,4-METHYLENEDIOXIMETHAMPHETAMINE-INDUCED MITOCHONDRIAL NEUROTOXICITY IN THE ADOLESCENT RAT BRAIN
E. Alves et al.
NEUROSCIENCE (2009)
Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain:: antioxidant and neuroprotective effects of L-carnitine
Daniela Silva-Adaya et al.
JOURNAL OF NEUROCHEMISTRY (2008)
A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis
Lis Eversden et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial
V Tomassini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
SA Montgomery et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder
LJ Van Oudheusden et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression
JW Pettegrew et al.
MOLECULAR PSYCHIATRY (2000)
Share Paper
